GlaxoSmithKline plc (GSKN) — Cash Flow Quality Index
GlaxoSmithKline plc (GSKN) has a Cash Flow Quality Index of 1.10x as of September 2025. Operating cash flow of MX$2.22 Billion exceeds net income of MX$2.01 Billion, indicating high earnings quality where cash backs reported profits. Explore GlaxoSmithKline plc (GSKN) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GlaxoSmithKline plc Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for GlaxoSmithKline plc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GlaxoSmithKline plc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for GlaxoSmithKline plc (2013–2024)
Year-by-year earnings quality comparison for GlaxoSmithKline plc. For live market cap and the full company financial profile, see market cap of GlaxoSmithKline plc.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.55x | MX$6.55 Billion | MX$2.58 Billion | ▲ +129.0% |
| 2023 | 1.11x | MX$5.48 Billion | MX$4.93 Billion | ▲ +124.5% |
| 2022 | 0.49x | MX$7.40 Billion | MX$14.96 Billion | ▼ -72.7% |
| 2021 | 1.81x | MX$7.95 Billion | MX$4.38 Billion | ▲ +23.5% |
| 2020 | 1.47x | MX$8.44 Billion | MX$5.75 Billion | ▼ -15.0% |
| 2019 | 1.73x | MX$8.02 Billion | MX$4.64 Billion | ▼ -25.7% |
| 2018 | 2.32x | MX$8.42 Billion | MX$3.62 Billion | ▼ -48.5% |
| 2017 | 4.52x | MX$6.92 Billion | MX$1.53 Billion | ▼ -36.6% |
| 2016 | 7.12x | MX$6.50 Billion | MX$912.00 Million | ▲ +2235.4% |
| 2015 | 0.31x | MX$2.57 Billion | MX$8.42 Billion | ▼ -83.8% |
| 2014 | 1.88x | MX$5.18 Billion | MX$2.76 Billion | ▲ +41.4% |
| 2013 | 1.33x | MX$7.22 Billion | MX$5.44 Billion | — |